DURASEAL DURAL SEALANT SYSTEM

Sealant, Dural

FDA Premarket Approval P040034

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the duraseal dural sealant system. The device is indicated for use as an adjunct to sutured dural repair during cranial surgery to provide watertight closure. Duraseal should only be used with autologous duraplasty material.

DeviceDURASEAL DURAL SEALANT SYSTEM
Classification NameSealant, Dural
Generic NameSealant, Dural
ApplicantINTEGRA LIFESCIENCES CORPORATION
Date Received2004-07-20
Decision Date2005-04-07
Notice Date2005-05-18
PMAP040034
SupplementS
Product CodeNQR
Docket Number05M-0191
Advisory CommitteeNeurology
Expedited ReviewNo
Combination Product No
Applicant Address INTEGRA LIFESCIENCES CORPORATION 311 Enterprise Dr. plainsboro, NJ 08536
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P040034Original Filing
S035 2022-09-07 30-day Notice
S034 2021-10-18 30-day Notice
S033
S032 2020-08-17 30-day Notice
S031 2020-05-15 Real-time Process
S030 2019-12-30 Normal 180 Day Track No User Fee
S029 2019-06-11 30-day Notice
S028 2018-10-29 30-day Notice
S027 2017-11-30 Normal 180 Day Track No User Fee
S026 2017-07-21 30-day Notice
S025 2016-04-18 Real-time Process
S024 2014-07-08 Normal 180 Day Track
S023 2014-02-11 30-day Notice
S022
S021 2013-06-04 135 Review Track For 30-day Notice
S020 2011-08-25 135 Review Track For 30-day Notice
S019 2010-12-23 Special (immediate Track)
S018
S017 2010-08-20 30-day Notice
S016 2010-01-08 Normal 180 Day Track No User Fee
S015 2009-10-26 30-day Notice
S014 2009-10-13 Real-time Process
S013 2009-08-11 Real-time Process
S012 2009-07-29 30-day Notice
S011 2009-06-23 Normal 180 Day Track No User Fee
S010
S009 2007-05-15 Real-time Process
S008 2007-03-01 30-day Notice
S007 2006-08-24 Real-time Process
S006 2006-07-28 Normal 180 Day Track
S005 2006-06-13 Normal 180 Day Track No User Fee
S004 2006-06-08 Normal 180 Day Track
S003 2006-05-24 Normal 180 Day Track No User Fee
S002 2005-11-17 Real-time Process
S001 2005-09-01 Real-time Process

NIH GUDID Devices

Device IDPMASupp
10381780000020 P040034 024
10381780000013 P040034 024

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.